News Release 

Re:GEN Open, dynamic new peer-reviewed open access journal

Mary Ann Liebert, Inc./Genetic Engineering News

Science Business Announcement

New Rochelle, NY, February 3, 2021--Mary Ann Liebert, Inc., publishers and Genetic Engineering & Biotechnology News (GEN) announce the launch of Re:GEN Open, the new multidisciplinary open access journal for scientifically rigorous research in the life and medical sciences.

Re:GEN Open combines the dynamic, global media presence of GEN with the scientific peer-reviewed publishing expertise of Mary Ann Liebert, Inc. to deliver an unprecedented publishing experience: best-in-class author services, rapid and fair peer review, and international exposure across the leading media platforms in the industry.

"Re:GEN Open is an important new multidisciplinary open access journal offering researchers around the world an opportunity to publish important discoveries across the life and medical sciences in an instantly accessible fashion," says Kevin Davies, PhD, Executive Vice President of GEN and Executive Editor of Re:GEN Open. "Re:GEN Open will consider direct submissions as well as papers referred by other Mary Ann Liebert, Inc. journals."

Re:GEN Open will publish fully open access original research, reviews, and frontmatter across all areas of the life sciences, including drug discovery, OMICS, genome editing, bioprocessing, translational medicine, cancer research, infectious diseases, and artificial intelligence. Authors who publish in Re:GEN Open will benefit from a dynamic, end-to-end publishing experience that ensures authoritative, credible peer review and unprecedented exposure for their published work across the Mary Ann Liebert, Inc. and GEN global audiences.


For further information, to sign up for email alerts, or to submit your manuscript, please visit the Re:GEN Open information page.

About Mary Ann Liebert, Inc., publishers

Founded by Mary Ann Liebert in 1980, Mary Ann Liebert, Inc., publishers is a leading independent publisher of scientific, technical, and medical content, known worldwide for its prescience and establishment of authoritative peer-reviewed journals, books, and trade publications in cutting-edge fields. Driven by her visionary passion and ceaseless curiosity, Mary Ann Liebert identifies and nurtures critical topics and cutting-edge fields by creating first-to-market, specialized publications that play a vital role in advancing research and facilitating collaboration in academia, industry, and government. For complete information, please visit the Mary Ann Liebert, Inc., publishers website.

About Genetic Engineering & Biotechnology News (GEN)

Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities. With nearly 40 years of publishing experience, GEN maintains unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry. For complete information, please visit the GEN website.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.